Navigation Links
Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
Date:9/19/2013

NEW YORK, Sept. 19, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW), concerning whether the board has breached its fiduciary duties to shareholders.

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO)

On April 23, 2013, Edwards disclosed that numerous candidate hospitals had postponed training for the Company's SAPIEN device, that there was no significant backlog of patients for SAPIEN implants, and that the Company's financial results had been weaker than guidance, and would likely continue to be.     

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Edwards shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email:  bsachsmichaels@hfesq.com
Website:  http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Updated: LHA Life Sciences & Medical Technologies Virtual Conference
2. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
3. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
5. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
6. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
7. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
8. FDAnews Announces Medical Device Mobile Apps Virtual Conference - Oct. 3, 2013
9. Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter And Full-Year Financial Results Conference Call And Webcast
10. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
11. Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... the quarter and full fiscal year ended December 31, 2016. ... ... Company,s audited financial statements and management discussion and analysis for ... been filed on SEDAR and are available at www.sedar.com ...
(Date:2/22/2017)... Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Fourth Quarter 2016 investor conference call and webcast at ... The call will cover an update on Merrimack,s recent ... full year 2016 financial results. A press release detailing the ... the morning of Wednesday, March 1. Investors and the general ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... , ... The Waismann Method® is providing a faster, safer, and ... victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... the shame, stigma, and harmful labeling believed to prevent many of these ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important webinar— ... 23, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , If you want to find out what really happened in the seniors ...
Breaking Medicine News(10 mins):